Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Proteome Research

• Publication date

  2006-01-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/PR050328XPMID 16457596
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.

  2005cited by this paper
• Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics

  2004cited by this paper
• Comparative proteomic analysis of de‐N‐glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status

  2004cited by this paper
• Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins.

  2003cited by this paper
• Abnormal glycosylation and altered Golgi structure in colorectal cancer: dependence on intra‐Golgi pH

  2002cited by this paper
• A Proteomic Approach for the Discovery of Early Detection Markers of Hepatocellular Carcinoma

  2002cited by this paper
• Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: Therapeutic implications

  2001cited by this paper
• Non-surgical treatment of hepatocellular carcinoma (HCC).

  2000cited by this paper
• Estimates of the worldwide incidence of 25 major cancers in 1990

  1999cited by this paper
• Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma

  1999cited by this paper
• Management of hepatitis C: current and future perspectives.

  1999cited by this paper
• Identification of highly fucosylated N-linked oligosaccharides from the human parotid gland.

  1998cited by this paper
• The fucosylation index of alpha-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma.

  1998cited by this paper
• The treatment of chronic viral hepatitis.

  1997cited by this paper
• A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles.

  1996cited by this paper
• Hepatitis B and C viruses and primary liver cancer.

  1995cited by this paper
• Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.

  1994cited by this paper
• Structural analysis on the sugar chains of human alpha 1-antitrypsin: presence of fucosylated biantennary glycan in hepatocellular carcinoma.

  1993cited by this paper
• Differences in glycosylation state of fibronectin from two rat colon carcinoma cell lines in relation to tumoral progressiveness.

  1989cited by this paper
• Hepatitis B virus. The major etiology of hepatocellular carcinoma

  1988cited by this paper
• Analyses of protein extracts of human breast cancers: changes in glycoprotein content linked to the malignant phenotype.

  1987cited by this paper
• Hepatitis B virus (HBV) and hepatocellular carcinoma. HBV DNA status and its implications.

  1987cited by this paper
• Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG

  1985cited by this paper
• Serum alpha fetoprotein heterogeneity as a means of differentiating between primary hepatocellular carcinoma and hepatic secondaries.

  1984cited by this paper
• Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.

  1984cited by this paper

• Serum N-glycomics for non-invasive detection of significant liver pathology across clinical phases of treatment-naïve chronic hepatitis B

  2025cites this paper
• Comparative Glycoproteomic Analysis of Mouse 4T1 Breast Cancer Model.

  2025cites this paper
• Selection of optimal protein sets as serological tumor marker signatures.

  2025cites this paper
• Diagnosis of hepatocellular carcinoma using liquid biopsy-based biomarkers: a systematic review and network meta-analysis

  2025cites this paper
• Phthalates promote lenvatinib resistance in hepatocellular carcinoma through the HPX-MAPK pathway.

  2025cites this paper
• Hemopexin Suppresses Hepatocellular Carcinoma via TNF-α-Mediated Mitochondrial Apoptosis

  2025cites this paper
• A “One-Step” Strategy for the Global Characterization of Core-Fucosylated Glycoproteome

  2024cites this paper
• Spatial omics-based machine learning algorithms for the early detection of hepatocellular carcinoma

  2024cites this paper
• Recent Developments and Application of Mass Spectrometry Imaging in N-Glycosylation Studies: An Overview

  2024cites this paper
• Integrating transcriptomics, glycomics and glycoproteomics to characterize hepatitis B virus-associated hepatocellular carcinoma

  2024cites this paper
• Site-specific N-glycan alterations on haptoglobin as potential biomarkers for distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma.

  2024cites this paper
• Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma

  2024cites this paper
• Exploring Fucosylation in Lung Cancer: Mechanisms, Diagnosis, and Therapeutic Strategies

  2024cites this paper
• Spatial Omics Reveals that Cancer-Associated Glycan Changes Occur Early in Liver Disease Development in a Western Diet Mouse Model of MASLD.

  2024cites this paper
• Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications

  2023cites this paper
• The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions

  2023cites this paper
• Histomolecular characterisation of hepatitis B virus induced liver cancer

  2023cites this paper
• Lens culinaris agglutinin inhibits human hepatoma cell migration via mannose and fucose-mediated ERK1/2 and JNK1/2/3 signalling pathway

  2022cites this paper
• Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers

  2022cites this paper
• GlycoFibroTyper: A Novel Method for the Glycan Analysis of IgG and the Development of a Biomarker Signature of Liver Fibrosis

  2022cites this paper
• A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation

  2022cites this paper
• A Biomarker Panel Based upon AFP, Fucosylated Kininogen and PEG-Precipitated IgG Is Highly Accurate for the Early Detection Hepatocellular Carcinoma in Patients with Cirrhosis in Phase II and Phase III Biomarker Evaluation

  2022cites this paper
• Hemopexin and Cancer

  2022cites this paper
• Fucosyltransferase 8 is Overexpressed and Influences Clinical Outcomes in Lung Adenocarcinoma Patients

  2022cites this paper
• Liver Cancer (Current Therapies)

  2021cites this paper
• The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers

  2021cites this paper
• Immunoglobulin G Glycosylation in Diseases.

  2021cites this paper
• Applications and continued evolution of glycan imaging mass spectrometry.

  2021cites this paper
• Glycan Imaging Mass Spectrometry: Progress in Developing Clinical Diagnostic Assays for Tissues, Biofluids, and Cells.

  2021cites this paper
• N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes

  2021cites this paper
• A Load to Find Clinically Useful Biomarkers for Depression.

  2021cites this paper
• Mass spectrometry imaging in lipid and proteomic profiling: an emerging tool for cancer diagnosis

  2020cites this paper
• Biomarkers for the Early Detection of Hepatocellular Carcinoma

  2020cites this paper
• Stromal expression of hemopexin is associated with lymph-node metastasis in pancreatic ductal adenocarcinoma

  2020cites this paper
• CEBP FOCUS Biomarkers for the Early Detection of Hepatocellular Carcinoma

  2020cites this paper
• A Potential Serum N-glycan Biomarker for Hepatitis C Virus-Related Early-Stage Hepatocellular Carcinoma with Liver Cirrhosis

  2020cites this paper
• An integrated strategy for large-scale investigation on protein core fucosylation stoichiometry based on Glycan-Simplification and Paired-Peaks-Extraction.

  2020cites this paper
• Serum profile of low molecular weight fucosylated glycoproteins for early diagnosis of hepatocellular carcinoma

  2020cites this paper
• The diagnostic value of serum DSA-TRF in hepatocellular carcinoma

  2020cites this paper
• Stage-associated differences in the serum N- and O-glycan profiles of patients with non-small cell lung cancer

  2019cites this paper
• Plasma proteome plus site‐specific N‐glycoprofiling for hepatobiliary carcinomas

  2019cites this paper
• Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review

  2019cites this paper
• Protein Glycosylation: An Important Tool for Diagnosis or Early Detection of Diseases

  2019cites this paper
• The potential of glycomics as prognostic biomarkers in liver disease and liver transplantation.

  2019cites this paper
• Mass spectrometry analysis reveals aberrant N-glycans in colorectal cancer tissues.

  2019cites this paper
• Fucosylation in cancer biology and its clinical applications.

  2019cites this paper
• protein glycosylation as a diagnostic and prognostic marker of chronic inflammatory gastrointestinal and liver diseases.

  2019cites this paper
• Analysis of Hepatocellular Carcinoma Tissue for Biomarker Discovery

  2019cites this paper
• Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma

  2019cites this paper
• Studying the Impact of Golgi Protein 73 Serving as a Candidate Biomarker in Early Diagnosis for Hepatocellular Carcinoma among Saudi Patients

  2019cites this paper
• Optimized Fragmentation for Quantitative Analysis of Fucosylated N-Glycoproteins by LC-MS-MRM.

  2019cites this paper
• Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.

  2018cites this paper
• Biomarker analysis of fucosylated kininogen through depletion of lectin reactive heterophilic antibodies in hepatocellular carcinoma.

  2018cites this paper
• The Function of Fucosylation in Progression of Lung Cancer

  2018cites this paper
• Use of Mass Spectrometry to Screen Glycan Early Markers in Hepatocellular Carcinoma

  2018cites this paper
• Quantitative analysis of core fucosylation of serum proteins in liver diseases by LC-MS-MRM.

  2018cites this paper
• Immunoglobulin G glycosylation in aging and diseases.

  2018cites this paper
• N-Linked Glycan Branching and Fucosylation Are Increased Directly in Hcc Tissue As Determined through in Situ Glycan Imaging.

  2018cites this paper
• The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome

  2018cites this paper
• Quantitative Analysis of Sex-Hormone-Binding Globulin Glycosylation in Liver Diseases by Liquid Chromatography-Mass Spectrometry Parallel Reaction Monitoring.

  2018cites this paper
• Protein glycosylation in viral hepatitis-related HCC: Characterization of heterogeneity, biological roles, and clinical implications.

  2017cites this paper
• COMMD7 promotes hepatocellular carcinoma through regulating CXCL10.

  2017cites this paper
• Epigenetic Bases of Aberrant Glycosylation in Cancer

  2017cites this paper
• Identification of fucosylated Fetuin‐A as a potential biomarker for cholangiocarcinoma

  2017cites this paper
• Changes in the Glycosylation of Kininogen and the Development of a Kininogen-Based Algorithm for the Early Detection of HCC

  2017cites this paper
• A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma

  2017cites this paper
• Identification of Core-Fucosylated Glycoproteome in Human Plasma.

  2017cites this paper
• Intrinsic hepatocyte dedifferentiation is accompanied by upregulation of mesenchymal markers, protein sialylation and core alpha 1,6 linked fucosylation

  2016cites this paper
• Identification of IgM as a contaminant in lectin-FLISA assays for HCC detection.

  2016cites this paper
• Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients

  2016cites this paper
• Glycan Node Analysis: A Bottom-up Approach to Glycomics.

  2016cites this paper
• Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs

  2016cites this paper
• Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma

  2016cites this paper
• Clinical diagnostics and therapy monitoring in the congenital disorders of glycosylation

  2016cites this paper
• Analysis of fucosylation in liver-secreted N-glycoproteins from human hepatocellular carcinoma plasma using liquid chromatography with tandem mass spectrometry

  2016cites this paper
• The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases

  2016cites this paper
• A glucose/mannose binding lectin from litchi (Litchi chinensis) seeds: Biochemical and biophysical characterizations

  2016cites this paper
• Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.

  2015cites this paper
• The Doylestown algorithm – a test to improve the performance of AFP in the detection of hepatocellular carcinoma

  2015cites this paper
• Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review

  2015cites this paper
• Revealing Glycoproteins in the Secretome of MCF-7 Human Breast Cancer Cells

  2015cites this paper
• Structural heterogeneity of glycoform of alpha-1 Acid glycoprotein in alcoholic cirrhosis patients.

  2015cites this paper
• Glycosylation and liver cancer.

  2015influential citation
• Quantification of biopharmaceuticals and biomarkers in complex biological matrices: a comparison of liquid chromatography coupled to tandem mass spectrometry and ligand binding assays

  2015cites this paper
• Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis.

  2015cites this paper
• Biochemical Roles of Eukaryotic Cell Surface Macromolecules

  2015cites this paper
• Glycosylation-related Diagnostic and Therapeutic Drug Target Markers in Hepatocellular Carcinoma.

  2015cites this paper
• Quantitative chemical proteomics for investigating the biomarkers of dioscin against liver fibrosis caused by CCl4 in rats.

  2015cites this paper
• A precise approach in large scale core-fucosylated glycoprotein identification with low- and high-normalized collision energy.

  2015cites this paper
• The role of proteomics in colorectal cancer biomarker discovery

  2015cites this paper
• Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry

  2015cites this paper
• Quantification of Fucosylated Hemopexin and Complement Factor H in Plasma of Patients with Liver Disease

  2014cites this paper
• Aplicación de la electroforesis bidimensional en diferentes especies: Vibrio tapetis , Pseudoscleropodium purum y Mus musculus

  2014cites this paper
• New possibilities in hepatocellular carcinoma treatment.

  2014cites this paper
• Regulation and function of silayltransferases in pancreatic cancer

  2014cites this paper
• QUANTITATIVE MASS SPECTROMETRIC ANALYSIS OF GLYCOPROTEINS COMBINED WITH ENRICHMENT METHODS

  2014cites this paper
• Decreased Core-Fucosylation Contributes to Malignancy in Gastric Cancer

  2014influential citation
• Strategy integrating stepped fragmentation and glycan diagnostic ion-based spectrum refinement for the identification of core fucosylated glycoproteome using mass spectrometry.

  2014cites this paper
• The re-emergence of the GP73 and fucosylated liver cancer biomarkers

  2014cites this paper
• Novel glycobiomarker for ovarian cancer that detects clear cell carcinoma.

  2014cites this paper